PHOENIX--(BUSINESS WIRE)--Zila, Inc. (NASDAQ:ZILA) today announced that it plans to launch its proprietary oral cancer screening product, ViziLite ® Plus with TBlue™, in the United Kingdom at the ...
ViziLite Plus with TBlue is an FDA-approved medical device for the early detection of oral cancer. "The marketing of ViziLite Plus in Russia and Belarus represents a solid step in our plan to provide ...
Chances are that you’re not thinking about oral cancer when you go for a dental exam, but your dentist is probably checking you for it. Many dentists do a visual examination for signs of oral cancer, ...
Chemical luminescence can aid in the visualization of oral leukoplakias, according to a study in the Journal of Oral Pathology and Medicine (August 2011, Vol. 40:7, pp. 541-544). Following oral ...
CASTRO VALLEY and SAN LEANDRO, Calif., April 7, 2008 Atiny lightstick -- called ViziLite Plus -- could help prevent 90 percent ofall fatalities from oral cancer, according to the East Bay-based ...
WMTO to distribute ViziLite oral exam kit and OraTest cancer detection products for Zila in Asia In Asia, oropharyngeal cancer is the leading cancer in men, and the third most frequent cancer site in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results